nach oben

Journal of Gastrointestinal Surgery

Erschienen in:

30.11.2022 | Original Article

Increased Expression of POSTN Predicts Poor Prognosis: a Potential Therapeutic Target for Gastric Cancer

verfasst von: Shuaibing Lu, Liangqun Peng, Fei Ma, Junhui Chai, Yawei Hua, Wei Yang, Zhandong Zhang

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Periostin (POSTN) is involved in many biological processes and is associated with the occurrence and development of several cancers, while its role in gastric cancer is not clear. We aimed to demonstrate the relationship between POSTN and gastric cancer based on publicly available data from The Cancer Genome Atlas (TCGA) database.

Methods

POSTN expression data and corresponding clinical information were downloaded from TCGA database. We compared the expression of POSTN in gastric cancer samples and normal samples. POSTN-related differentially expressed genes (DEGs) were identified for further functional enrichment analysis. In addition, the relationships between POSTN expression and clinicopathological features and survival in patients with gastric cancer were also investigated through univariate and multivariate Cox regression analyses. Furthermore, a nomogram was constructed to predict the survival probability of gastric cancer patients.

Results

POSTN expression in gastric cancer was significantly higher than that in normal gastric tissues (p < 0.001). High POSTN expression in gastric cancer was significantly related to poor prognostic features, including greater tumor extent (odds ratio [OR] = 1.638 for T3 and T4 vs. T1 and T2), worse histological type (OR = 0.329 for diffuse type vs. tubular type), and advanced histological grade (OR = 1.646 for grade 3 vs. grades 1 and 2) (all p < 0.05). The 118 identified DEGs were primarily enriched in pathways related to tumorigenesis and tumor progression, including the TGF-β signaling pathway, the WNT signaling pathway, and the signaling by VEGF. POSTN expression was positively correlated with the enrichment of the macrophages (r = 0.599, p < 0.001), helper T2 cells (r = 0.146, p = 0.005), and CD8 + T cells (r = 0.190, p < 0.001), but negatively correlated with the enrichment of Th17 cells (r = − 0.130, p = 0.012) and NK CD56bright cells. Kaplan–Meier survival analysis showed that high POSTN expression is associated with a short overall survival (hazard ratio [HR] = 1.54; p = 0.011). In the multivariate cox regression analysis, high POSTN expression was confirmed to be an independent predictor of poor overall survival (HR = 1.681; p = 0.017). The constructed nomogram can well predict the 1 and 3 years overall survival probability of patients with GC (0.696 [95% CI, 0.671–0.721]).

Conclusion

POSTN plays an important role in the progression and prognosis of gastric cancer, and it may serve as a useful biomarker to predict survival in gastric cancer patients.

Nur mit Berechtigung zugänglich

Sung H, Ferlay J, Rebecca L, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: Cancer J Clin 2021;0:1–41. https://doi.org/10.3322/caac.21660.

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of18 cancers from 322 population-based registries in 71 countries. Lancet. (2018) 391:1023–75. https://doi.org/10.1016/S0140-6736(17)33326-3CrossRefPubMedPubMedCentral

Winkler J, Abisoye-Ogunniyan A, Metcalf K, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020 Oct 9;11(1):5120. https://doi.org/10.1038/s41467-020-18794-x

Malanchi I, Santamaria-Martínez A, Susanto E, Peng H, Lehr H, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature (2011) 481, 85–89. https://doi.org/10.1038/nature10694CrossRefPubMed

Ratajczak-Wielgomas K, Kmiecik A, Dziegiel P. Role of Periostin Expression in Non-Small Cell Lung Cancer: Periostin Silencing Inhibits the Migration and Invasion of Lung Cancer Cells via Regulation of MMP-2 Expression. Int J Mol Sci. 2022 22;23(3):1240. https://doi.org/10.3390/ijms23031240.

Ma Y, He L, Zhao X, Li W, Lv X, et al. Protease activated receptor 2 signaling promotes self-renewal and metastasis in colorectal cancer through β-catenin and periostin. Cancer Lett. 2021 27;521:130-141. https://doi.org/10.1016/j.canlet.2021.08.032CrossRef

Yu B, Wu K, Wang X, Zhang J, Wang L, et al. Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7. Cell Death Dis. 2018 22;9(11):1082. https://doi.org/10.1038/s41419-018-1116-6.

Underwood T, Hayden A, Derouet M, Garcia E, Noble F, et al. Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma. J Pathol. 2015; 235(3):466-77. https://doi.org/10.1002/path.4467CrossRefPubMedPubMedCentral

Lv Y, Wang W, Jia W, Sun Q, Huang M, et al. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy. Eur J Surg Oncol. 2013 Oct;39(10):1129-35. https://doi.org/10.1016/j.ejso.2013.06.023

10.

Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. (2014) 15:550. https://doi.org/10.1186/s13059-014-0550-8CrossRefPubMedPubMedCentral

11.

Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. (2012) 16:284–7. https://doi.org/10.1089/omi.2011.0118CrossRefPubMedPubMedCentral

12.

Subramanian A, Tamayo P, Mootha V K, Mukherjee S, Ebert B, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A, 2005, 102(43): 15545-15550. https://doi.org/10.1073/pnas.0506580102CrossRefPubMedPubMedCentral

13.

Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC bioinformatics 14.1 (2013): 1-15. https://doi.org/10.1186/1471-2105-14-7CrossRef

14.

Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39.4 (2013): 782-795. https://doi.org/10.1016/j.immuni.2013.10.003CrossRefPubMed

15.

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic acids research, 2019, 47(D1): D607-D613. https://doi.org/10.1093/nar/gky1131CrossRefPubMed

16.

Gabor C, Nepusz T. The igraph software package for complex network research. Inter Journal, complex systems 1695.5 (2006): 1–9. https://www.researchgate.net/publication/221995787

17.

Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. (2011) 12:77. https://doi.org/10.1186/1471-2105-12-77CrossRefPubMedPubMedCentral

18.

Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. (2017) 35:314-6. https://doi.org/10.1038/nbt.3772CrossRefPubMedPubMedCentral

19.

Wong M, Huang J, Chan P, Choi P, Lao X, et al. Global Incidence and Mortality of Gastric Cancer, 1980-2018. JAMA Netw Open. 2021 Jul 1;4(7):e2118457.

20.

Allemani C, Matsuda T, Carlo V, Harewood R, Matz M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018 Mar 17;391(10125):1023-1075. https://doi.org/10.1016/S0140-6736(17)33326-3

21.

Yue H, Li W, Chen R, et al. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer. Gynecol Oncol. 2021 Feb;160(2):530-538. https://doi.org/10.1016/j.ygyno.2020.11.026

22.

Ouyang G, Liu M, Ruan K, Song G, Mao Y, et al. Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway. Cancer Lett. 2009 28;281(2):213–9. https://doi.org/10.1016/j.canlet.2009.02.030

23.

Kim G, Lee J, Park M, Yoon J. Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma. PLoS One. 2017 Nov 21;12(11):e0187635. https://doi.org/10.1371/journal.pone.0187635

24.

Labrèche C, Cook D, Abou-Hamad J, et al. Periostin gene expression in neu-positive breast cancer cells is regulated by a FGFR signaling cross talk with TGFβ/PI3K/AKT pathways. Breast Cancer Res. 2021 Nov 22;23(1):107. https://doi.org/10.1186/s13058-021-01487-8

25.

Bowen D, Joong S. Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer. Molecules, 2016, 21(7):965. https://doi.org/10.3390/molecules21070965CrossRef

26.

Massague J. TGFβ in cancer. Cell. 2008;134(2):215-230. https://doi.org/10.1016/j.cell.2008.07.001CrossRefPubMedPubMedCentral

27.

Batlle E, Massague J. Transforming growth factor-beta signaling in immunity and cancer. Immunity. 2019;50(4):924-940. https://doi.org/10.1016/j.immuni.2019.03.024CrossRefPubMedPubMedCentral

28.

Yan Y, Zhang J, Li JH, et al. High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial-mesenchymal transition in gastric cancer. OncoTargets and Therapy, 2016(9): 3975-3983. https://doi.org/10.2147/OTT.S103112CrossRefPubMedPubMedCentral

29.

Herr P, Hausmann G, Basler K. WNT secretion and signalling in human disease. Trends Mol Med, 2012;18(8):483-93. https://doi.org/10.1016/j.molmed.2012.06.008CrossRefPubMed

30.

Nusse R, Clevers H. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985–99. https://doi.org/10.1016/j.cell.2017.05.016CrossRefPubMed

31.

Wang Y, Zheng L, Shang W, Yang Z, Li T, et al. Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer. Cell Death Differ. 2022. https://doi.org/10.1038/s41418-022-01008-wCrossRefPubMedPubMedCentral

32.

Pang L, Wang J, Fan Y, Xu R, Bai Y, et al. Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression. Cancer Biomark. 2018;23(1):53-59. https://doi.org/10.3233/CBM-181287CrossRefPubMed

33.

Yan R, Peng X, Yuan X, et al. Suppression of growth and migration by blocking the Hedgehog signaling pathway in gastric cancer cells. Cell Oncol, 2013, 36(5):421-435. https://doi.org/10.1007/s13402-013-0149-1CrossRef

34.

Murakami D, Tsujitani S, Osaki T, Saito H, Katano K, et al. Expression of phosphorylated Akt (pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy. Gastric Cancer. 2007;10(1):45-51. https://doi.org/10.1007/s10120-006-0410-7CrossRefPubMed

35.

Hu Y, Zheng M, Zhang R, Liang Y, Han H. Notch Signaling Pathway and Cancer Metastasis. Adv Exp Med Biol. 2012, 727, 186–198. https://doi.org/10.1007/978-1-4614-0899-4_14CrossRefPubMed

36.

Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549–555 (2002). https://doi.org/10.1016/s1471-4906(02)02302-5CrossRefPubMed

37.

Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 454, 436–444. https://doi.org/10.1038/nature07205

38.

Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141(1):39-51. https://doi.org/10.1016/j.cell.2010.03.014.CrossRefPubMedPubMedCentral

39.

Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014; 41(1):49-61. https://doi.org/10.1016/j.immuni.2014.06.010.CrossRefPubMedPubMedCentral

40.

Ubukata H, Motohashi G, Tabuchi T, Nagata H, Konishi S, et al. Evaluations of interferon-γ/interleuki‑4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol. 2010 1;102(7):742–7. https://doi.org/10.1002/jso.21725

41.

Chen J, Xia J, Liang X, Pan K, Wang W, et al. Intratumoral expression of IL‑17 and its prognostic role in gastric adenocarcinoma patients. Int. J. Biol. Sci. 7, 53–60 (2011). Int J Biol Sci. 2011 Jan 11;7(1):53–60. https://doi.org/10.7150/ijbs.7.53

Titel: Increased Expression of POSTN Predicts Poor Prognosis: a Potential Therapeutic Target for Gastric Cancer
verfasst von: Shuaibing Lu
Liangqun Peng
Fei Ma
Junhui Chai
Yawei Hua
Wei Yang
Zhandong Zhang
Publikationsdatum: 30.11.2022
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Surgery / Ausgabe 2/2023
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-022-05517-4

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

Are IBD Patients Underscored when Determining Postoperative VTE Risk?

Novel Traction Method by STRATAFIX Symmetric (Pulley Maneuver) in Laparoscopic Hepatectomy

To the Editor: Reply to He J., Yin Y., Tang W., et al. Objective Outcomes of an Extended Anti-Reflux Mucosectomy in the Treatment of PPI-Dependent Gastroesophageal Reflux Disease (with Video). J Gastrointest Surg. 2022

Resection of Colorectal Liver Metastases: Prognostic Impact of Tumor Burden Score Varies with Unilateral Versus Bilateral Metastatic Spread

Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy

Incidence and Risk Factors of Surgical Complications and Anastomotic Leakage After Transanal Total Mesorectal Excision for Middle and Low Rectal Cancer

Update Chirurgie